Claire M. Lucas, Robert J. Harris, Athina Giannoudis, Andrea Davies, Katy Knight, Sarah J. Watmough, Lihui Wang, Richard E. Clark. Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript. haematol [Internet]. 2009Sep.30 [cited 2024Dec.22];94(10):1362-7. Available from: https://haematologica.org/article/view/5371